David J. Moliterno, MD

Vice President for Clinical Affairs, College of Medicine
Chair, Department of Internal Medicine

Practice areas

Practice areas

Clinical interests

  • Cardiovascular Disease
  • Coronary Interventions
  • Hypercoagulable Syndrome
  • Interventional Cardiology
  • Ischemic Heart Disease

David J. Moliterno, MD

Vice President for Clinical Affairs, College of Medicine
Chair, Department of Internal Medicine

Biography

My name is David Moliterno; I received my medical degree from the Medical College of Virginia, Richmond. I completed a fellowship at the University of Texas Southwestern Medical Center, Dallas.

I am board certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology.

Faculty rank

Professor of Medicine

Education

Degree
Medical College of Virginia, Richmond

Residency
Vanderbilt University Medical Center, Nashville, Tenn.

Fellowship
University of Texas Southwestern Medical Center, Dallas

Certifications or Special training
American Board of Internal Medicine, Interventional Cardiology 
American Board of Internal Medicine, Cardiovascular Disease

Cardiovascular Medicine

UK Albert B. Chandler Hospital - Pavilion G
Gill Heart Institute
First Floor
1000 S. Limestone
Lexington KY 40536-0602


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Yu J, Baber U, Mastoris I, Dangas G, Sartori S, Steg PG, Cohen DJ, Giustino G, Chandrasekhar J, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, Colombo A, Pocock S, Mehran R. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. JACC Cardiovasc Interv. 2016 Jul 25;9(14):1461-9.
    View in: PubMed
  2. Baber U, Dangas G, Chandrasekhar J, Sartori S, Steg PG, Cohen DJ, Giustino G, Ariti C, Witzenbichler B, Henry TD, Kini AS, Krucoff MW, Gibson CM, Chieffo A, Moliterno DJ, Weisz G, Colombo A, Pocock S, Mehran R. Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. JACC Cardiovasc Interv. 2016 Jul 11;9(13):1349-57.
    View in: PubMed
  3. Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. J Am Coll Cardiol. 2016 May 17;67(19):2224-34.
    View in: PubMed
  4. Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. J Am Coll Cardiol. 2016 May 10;67(18):2135-44.
    View in: PubMed
  5. Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ, White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW, Aylward PE, Strony J, Mahaffey KW, Gibson CM. Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy. Circ Cardiovasc Interv. 2016 May;9(5).
    View in: PubMed
  6. Dunn SP, Holmes DR, Moliterno DJ. Drug-drug interactions in cardiovascular catheterizations and interventions. JACC Cardiovasc Interv. 2012 Dec; 5(12):1195-208. PMID: 23257367.
    View in: PubMed
  7. Kalra N, Moliterno DJ. Zotarolimus-eluting stents among patients with renal impairment undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012 Nov 15; 80(6):893-4. PMID: 23166098.
    View in: PubMed
  8. Anaya P, Moliterno DJ. CT angiography for emergency decision making in acute coronary syndromes: applying future vision now. Curr Cardiol Rep. 2012 Oct; 14(5):537-9. PMID: 22890753.
    View in: PubMed
  9. Capodanno D, Bhatt DL, Goto S, O'Donoghue ML, Moliterno DJ, Tamburino C, Angiolillo DJ. Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials. J Thromb Haemost. 2012 Oct; 10(10):2006-15. PMID: 22845871.
    View in: PubMed
  10. El Mallah W, Moliterno DJ. Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement. Catheter Cardiovasc Interv. 2012 Sep 1; 80(3):406-7. PMID: 22933348.
    View in: PubMed
  11. Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, Linderbaum JA, Moliterno DJ, Weitz HH. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):e29-84. PMID: 22898522.
    View in: PubMed
  12. Wiisanen ME, Moliterno DJ. Platelet protease-activated receptor antagonism in cardiovascular medicine. Coron Artery Dis. 2012 Sep; 23(6):375-9. PMID: 22781741.
    View in: PubMed
  13. Rajan L, Moliterno DJ. New anticoagulants in ischemic heart disease. Curr Cardiol Rep. 2012 Aug; 14(4):450-6. PMID: 22528556.
    View in: PubMed
  14. van Diepen S, Roe MT, Lopes RD, Stebbins A, James S, Newby LK, Moliterno DJ, Neumann FJ, Ezekowitz JA, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Theroux P, Granger CB. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. J Thromb Thrombolysis. 2012 Jul; 34(1):106-13. PMID: 22307842.
    View in: PubMed
  15. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso AC, Harrington RA, Bates ER, Bhatt DL, Bridges CR, Eisenberg MJ, Ferrari VA, Fisher JD, Gardner T, Gentile F, Gilson MF, Hlatky MA, Jacobs AK, Kaul S, Moliterno DJ, Mukherjee D, Rosenson RS, Weitz HH, Wesley DJ. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine. Catheter Cardiovasc Interv. 2012 Sep 1; 80(3):E37-49. PMID: 22570114.
    View in: PubMed
  16. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso CL. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update. A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents. J Am Coll Cardiol. 2012 Jun 12; 59(24):2221-305. PMID: 22575325.
    View in: PubMed
  17. Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, Linderbaum JA, Moliterno DJ, Weitz HH. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Catheter Cardiovasc Interv. 2012 Jun 1; 79(7):1023-82. PMID: 22294439.
    View in: PubMed
  18. Foley JD, Moliterno DJ. Contemporary occurrence of stent thrombosis in clinical practice: better never than late. Catheter Cardiovasc Interv. 2012 Mar 1; 79(4):557-8. PMID: 22344988.
    View in: PubMed
  19. Abdel-Latif A, Moliterno DJ. Creating biodegradable-polymer drug-eluting stents: shortening the duration of polymer and dual antiplatelet therapy while lengthening the follow-up. Catheter Cardiovasc Interv. 2012 Feb 1; 79(2):217-8. PMID: 22271552.
    View in: PubMed
  20. Kristensen SD, Würtz M, Grove EL, De Caterina R, Huber K, Moliterno DJ, Neumann FJ. Contemporary use of glycoprotein IIb/IIIa inhibitors. Thromb Haemost. 2012 Feb; 107(2):215-24. PMID: 22234385.
    View in: PubMed
  21. Wallace EL, Abdel-Latif A, Charnigo R, Moliterno DJ, Brodie B, Matnani R, Ziada KM. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol. 2012 Apr 1; 109(7):932-40. PMID: 22221949.
    View in: PubMed
  22. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med. 2012 Jan 5; 366(1):20-33. PMID: 22077816.
    View in: PubMed
  23. Wallace EL, Moliterno DJ. The use of drug-eluting stents versus bypass surgery for left main coronary artery disease. Curr Cardiol Rep. 2011 Oct; 13(5):361-3. PMID: 21735107.
    View in: PubMed
  24. Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary. Circ Cardiovasc Interv. 2011 Oct 1; 4(5):522-34. PMID: 22010191.
    View in: PubMed
  25. Rajan L, Moliterno DJ. Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS? Curr Cardiol Rep. 2011 Aug; 13(4):303-11. PMID: 21607650.
    View in: PubMed
  26. Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost. 2011 Oct; 106(4):572-84. PMID: 21785808.
    View in: PubMed
  27. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Ann Forciea M, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ, Harrington RA, Bates ER, Bhatt DL, Bridges CR, Eisenberg MJ, Ferrari VA, Fisher JD, Gardner TJ, Gentile F, Gilson MF, Hlatky MA, Jacobs AK, Kaul S, Moliterno DJ, Mukherjee D, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011 Jul-Aug; 5(4):259-352. PMID: 21771565.
    View in: PubMed
  28. Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Van de Werf F, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, Braunwald E, Califf RM, Harrington RA. Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):448-58. PMID: 21712522.
    View in: PubMed
  29. Elayi CS, Whitbeck MG, Charnigo R, Shah J, Macaulay TE, Morales G, Gurley JC, Kakavand B, Thal S, Ching CK, Khaykin Y, Verma A, Barrett C, Bai R, Di Biase L, Patwardhan A, Moliterno DJ, Natale A. Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study. Circ Arrhythm Electrophysiol. 2011 Aug; 4(4):465-9. PMID: 21511994.
    View in: PubMed
  30. Anaya P, Moliterno DJ. Patient, heal thyself: the ongoing evolution of patient self-directed care and hand-held technology. Ann Intern Med. 2011 Apr 5; 154(7):500-1. PMID: 21464353.
    View in: PubMed
  31. Moliterno DJ. Unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low. Catheter Cardiovasc Interv. 2011 Feb 1; 77(2):191-2. PMID: 21290553.
    View in: PubMed
  32. Moliterno DJ. ACP Journal Club. Increased doses of clopidogrel or aspirin did not prevent cardiovascular events. Ann Intern Med. 2011 Jan 18; 154(2):JC1-7. PMID: 21242361.
    View in: PubMed
  33. Elayi CS, Allen CL, Leung S, Lusher S, Morales GX, Wiisanen M, Aikat S, Kakavand B, Shah JS, Moliterno DJ, Gurley JC. Inside-out access: a new method of lead placement for patients with central venous occlusions. Heart Rhythm. 2011 Jun; 8(6):851-7. PMID: 21237290.
    View in: PubMed
  34. Moliterno DJ. A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial. Catheter Cardiovasc Interv. 2011 Jun 1; 77(7):1001-9. PMID: 21598351.
    View in: PubMed
  35. Ziada KM, Charnigo R, Moliterno DJ. Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2011 Jan; 4(1):39-41. PMID: 21251627.
    View in: PubMed
  36. Holmes DR, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ. Stent thrombosis. J Am Coll Cardiol. 2010 Oct 19; 56(17):1357-65. PMID: 20946992.
    View in: PubMed
  37. Tackett AH, Bailey AL, Foody JM, Miller JM, Apperson-Hansen C, Ohman EM, Hochman JS, Karnash SL, Califf RM, Topol EJ, Moliterno DJ. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial. Am Heart J. 2010 Oct; 160(4):678-84. PMID: 20934562.
    View in: PubMed
  38. Moliterno DJ. Rotational atherectomy for resistant chronic total occlusions: another spin for tough old problems. Catheter Cardiovasc Interv. 2010 Sep 1; 76(3):372-3. PMID: 20839350.
    View in: PubMed
  39. Wiisanen ME, Moliterno DJ. The use of single versus dual antiplatelet therapy beyond 1 year following drug-eluting stent implantation. Curr Cardiol Rep. 2010 Sep; 12(5):357-60. PMID: 20544309.
    View in: PubMed
  40. Abdel-Latif A, Moliterno DJ. Editorial: protein C and S deficiency as a risk factor for stent thrombosis--when a rare disorder can predispose to rare events. J Interv Cardiol. 2010 Dec; 23(6):565-8. PMID: 20796164.
    View in: PubMed
  41. George JC, Moliterno DJ, Dangas GD. American College of Cardiology Annual Scientific Session 2010: update in interventional cardiology. JACC Cardiovasc Interv. 2010 May; 3(5):562-4. PMID: 20488415.
    View in: PubMed
  42. Means RT, Moliterno DJ, Allison GR, Perman JA, Lofgren RP, Karpf M, Debeer FC. The evolution of a Department of Internal Medicine under an integrated clinical enterprise model: the University of Kentucky experience. Acad Med. 2010 Mar; 85(3):531-7. PMID: 20182134.
    View in: PubMed
  43. Mukherjee D, Moliterno DJ. Second-generation drug-eluting stents and the continuous need for rapidly available real-world data. JACC Cardiovasc Interv. 2009 Dec; 2(12):1236-9. PMID: 20129550.
    View in: PubMed
  44. Lopes RD, Ohman EM, Granger CB, Honeycutt EF, Anstrom KJ, Berger PB, Crespo EM, Oliveira GB, Moll S, Moliterno DJ, Abrams CS, Becker RC. Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). Am J Cardiol. 2009 Nov 1; 104(9):1285-91. PMID: 19840578.
    View in: PubMed
  45. Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Am Heart J. 2009 Nov; 158(5):755-60. PMID: 19853693.
    View in: PubMed
  46. Valgimigli M, Biondi-Zoccai G, Tebaldi M, van't Hof AW, Campo G, Hamm C, ten Berg J, Bolognese L, Saia F, Danzi GB, Briguori C, Okmen E, King SB, Moliterno DJ, Topol EJ. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J. 2010 Jan; 31(1):35-49. PMID: 19755402.
    View in: PubMed
  47. Abdel-Latif A, Moliterno DJ. Prasugrel versus clopidogrel in primary PCI: considerations of the TRITON-TIMI 38 substudy. Curr Cardiol Rep. 2009 Sep; 11(5):323-4. PMID: 19709491.
    View in: PubMed
  48. Moliterno DJ. Left main and multivessel coronary artery stenting for patients deemed inoperable-A real need for a tandem approach. Catheter Cardiovasc Interv. 2009 Aug 1; 74(2):311-2. PMID: 19642179.
    View in: PubMed
  49. Holmes DR, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol. 2009 Jul 7; 54(2):95-109. PMID: 19573725.
    View in: PubMed
  50. Abdel-Latif A, Moliterno DJ. Antiplatelet polypharmacy in primary percutaneous coronary intervention: trying to understand when more is better. Circulation. 2009 Jun 30; 119(25):3168-70. PMID: 19528332.
    View in: PubMed
  51. Jolicoeur EM, Ohman EM, Honeycutt E, Becker RC, Crespo EM, Oliveira GB, Moliterno DJ, Anstrom KJ, Granger CB. Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin. Am J Cardiol. 2009 Jul 15; 104(2):292-7. PMID: 19576363.
    View in: PubMed
  52. Rajan L, Moliterno DJ. Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention. Eur Heart J. 2009 Jul; 30(14):1687-9. PMID: 19429914.
    View in: PubMed
  53. Koul S, Moliterno DJ. Bare-metal versus drug-eluting stent placement among patients presenting with anemia. JACC Cardiovasc Interv. 2009 Apr; 2(4):337-8. PMID: 19463446.
    View in: PubMed
  54. Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, Moliterno DJ, Van de Werf F, White HD, Harrington RA, Roe MT. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. Am Heart J. 2009 Apr; 157(4):716-23. PMID: 19332201.
    View in: PubMed
  55. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, Harrington RA, Anderson JL, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Grines CL, Hlatky MA, Jacobs AK, Kaul S, Lichtenberg RC, Lindner JR, Moliterno DJ, Mukherjee D, Pohost GM, Rosenson RS, Schofield RS, Shubrooks SJ, Stein JH, Tracy CM, Weitz HH, Wesley DJ. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009 Apr 28; 119(16):2250-94. PMID: 19332472.
    View in: PubMed
  56. Crespo EM, Oliveira GB, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, Ohman EM. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009 Apr; 157(4):651-7. PMID: 19332191.
    View in: PubMed
  57. Becker RC, Moliterno DJ, Jennings LK, Pieper KS, Pei J, Niederman A, Ziada KM, Berman G, Strony J, Joseph D, Mahaffey KW, Van de Werf F, Veltri E, Harrington RA. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet. 2009 Mar 14; 373(9667):919-28. PMID: 19286091.
    View in: PubMed
  58. Mukherjee D, Moliterno DJ. Effectiveness of PCI for non-acute coronary artery disease. Lancet. 2009 Mar 14; 373(9667):870-2. PMID: 19286067.
    View in: PubMed
  59. Moliterno DJ. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes. Catheter Cardiovasc Interv. 2009 Jan 1; 73(1):32-3. PMID: 19089933.
    View in: PubMed
  60. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Jan; 2(1):37-45. PMID: 19463396.
    View in: PubMed
  61. Moliterno DJ. Advances in antiplatelet therapy for ACS and PCI. J Interv Cardiol. 2008 Dec; 21 Suppl 1:S18-24. PMID: 19090933.
    View in: PubMed
  62. Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, Steinhubl SR, Becker RC. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2009 Apr; 29(4):449-57. PMID: 19023091.
    View in: PubMed
  63. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28; 52(18):1502-17. PMID: 19017521.
    View in: PubMed
  64. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008 Nov; 103(11):2890-907. PMID: 18853965.
    View in: PubMed
  65. Hamdalla H, Moliterno DJ. Late drug-eluting stent thrombosis in unprotected left main coronary artery lesions--sometimes possible, but rarely definite or probable. Eur Heart J. 2008 Sep; 29(17):2064-6. PMID: 18664463.
    View in: PubMed
  66. Moliterno DJ. Racial differences in outcome following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2008 Jul 1; 72(1):45-6. PMID: 18561154.
    View in: PubMed
  67. Moliterno DJ. Late percutaneous recanalization of totally occluded infarct-related arteries--more than about time. Catheter Cardiovasc Interv. 2008 May 1; 71(6):782-3. PMID: 18415953.
    View in: PubMed
  68. Salah AK, Ahmed A, Bodiwala KN, Manaloor EJ, Thornton JW, Moliterno DJ. Cardiac amyloidosis. Can J Cardiol. 2008 May; 24(5):e35. PMID: 18464954.
    View in: PubMed
  69. Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ruzyllo W, O'Neill WW, Hamm CW, Westerhout CM, Granger CB, Armstrong PW. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study. Eur Heart J. 2008 May; 29(9):1127-35. PMID: 18375399.
    View in: PubMed
  70. Moliterno DJ. Late target lesion revascularization following drug-eluting stents - looking back and forward to success. Catheter Cardiovasc Interv. 2008 Feb 15; 71(3):304-5. PMID: 18288752.
    View in: PubMed
  71. Moliterno DJ, Ziada KM. The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide. J Am Coll Cardiol. 2008 Feb 5; 51(5):536-7. PMID: 18237681.
    View in: PubMed
  72. Mukherjee D, Moliterno DJ. Effectiveness of drug-eluting stents in real-world patients. JAMA. 2008 Jan 30; 299(4):454-5. PMID: 18230785.
    View in: PubMed
  73. Oliveira GB, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Ohman EM, Granger CB. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008 Jan 14; 168(1):94-102. PMID: 18195201.
    View in: PubMed
  74. Novaro GM, Asher CR, Bhatt DL, Moliterno DJ, Harrington RA, Lincoff AM, Newby LK, Tcheng JE, Hsu AP, Pinski SL. Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites. Am J Cardiol. 2008 Feb 15; 101(4):506-9. PMID: 18312767.
    View in: PubMed
  75. Colasanti A, Natoli A, Moliterno D, Rossattini M, De Gaspari IF, Mauri MC. Psychiatric diagnosis and aggression before acute hospitalisation. Eur Psychiatry. 2008 Sep; 23(6):441-8. PMID: 18024087.
    View in: PubMed
  76. Salah A, Moliterno DJ, Humphries R, Syed MA. Role of cardiac computed tomography and magnetic resonance imaging in the evaluation of acute chest pain in the emergency department. Int J Cardiovasc Imaging. 2008 Mar; 24(3):331-42. PMID: 17849234.
    View in: PubMed
  77. Mardikar HM, Hiremath MS, Moliterno DJ, Mathew R, Arora R, Deo D, Hiremath JS, Deshpande NV, Khan A, Joseph J, Mukherjee D. Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study. Am Heart J. 2007 Aug; 154(2):344.e1-5. PMID: 17643586.
    View in: PubMed
  78. Moliterno DJ, Campbell CL. Unraveling questions surrounding clopidogrel resistance and stent thrombosis: one less snag. J Am Coll Cardiol. 2007 Jun 19; 49(24):2318-9. PMID: 17572246.
    View in: PubMed
  79. Dove JT, Moliterno DJ, Weaver WD, Shelton ME. President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry. J Am Coll Cardiol. 2007 Jun 5; 49(22):2223-6. PMID: 17543645.
    View in: PubMed
  80. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Dent Assoc. 2007 May; 138(5):652-5. PMID: 17473044.
    View in: PubMed
  81. Moliterno DJ. Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents. Catheter Cardiovasc Interv. 2007 May 1; 69(6):799-800. PMID: 17377984.
    View in: PubMed
  82. Moliterno DJ. The challenge of quantifying exceedingly rare occurrences: we can only see what we see. Catheter Cardiovasc Interv. 2007 Apr 1; 69(5):719-20. PMID: 17390302.
    View in: PubMed
  83. Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure R, Moliterno D. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?). Catheter Cardiovasc Interv. 2007 Apr 1; 69(5):623-9. PMID: 17192960.
    View in: PubMed
  84. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv. 2007 Feb 15; 69(3):334-40. PMID: 17295287.
    View in: PubMed
  85. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007 Feb 13; 49(6):734-9. PMID: 17291948.
    View in: PubMed
  86. Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL. In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol. 2007 Feb 27; 49(8):849-54. PMID: 17320742.
    View in: PubMed
  87. Mukherjee D, Moliterno DJ. The timely coupling of mechanical revascularization following thrombolysis for myocardial infarction. Cardiology. 2007; 107(4):337-9. PMID: 17268199.
    View in: PubMed
  88. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007 Feb 13; 115(6):813-8. PMID: 17224480.
    View in: PubMed
  89. Westerhout CM, Hernández AV, Steyerberg EW, Bueno H, White H, Théroux P, Moliterno DJ, Armstrong PW, Califf RM, Wallentin LC, Simoons ML, Boersma E. Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2006 Dec; 27(24):2956-61. PMID: 17093039.
    View in: PubMed
  90. Moliterno DJ. Randomized trial versus registry data--comparing apples and ORCHIDs. Catheter Cardiovasc Interv. 2006 Nov; 68(5):669-70. PMID: 17039505.
    View in: PubMed
  91. Hernández AV, Westerhout CM, Steyerberg EW, Ioannidis JP, Bueno H, White H, Theroux P, Moliterno DJ, Armstrong PW, Califf RM, Wallentin LC, Simoons ML, Boersma E. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups. Heart. 2007 Apr; 93(4):450-5. PMID: 17065179.
    View in: PubMed
  92. Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006 Oct 17; 48(8):1567-72. PMID: 17045889.
    View in: PubMed
  93. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol. 2006 Sep; 18(9):405-8. PMID: 16954577.
    View in: PubMed
  94. Moliterno DJ. Imminent extinction of brachy(saurus)therapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv. 2006 Sep; 68(3):349-51. PMID: 16894576.
    View in: PubMed
  95. Hamdalla H, Moliterno DJ. Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention. Expert Opin Pharmacother. 2006 Aug; 7(12):1669-73. PMID: 16872270.
    View in: PubMed
  96. Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J, Mukherjee D. Heparin-induced thrombocytopenia and cardiovascular diseases. Am Heart J. 2006 Jul; 152(1):19-26. PMID: 16824828.
    View in: PubMed
  97. Alexander KP, Newby LK, Bhapkar MV, White HD, Hochman JS, Pfisterer ME, Moliterno DJ, Peterson ED, Van de Werf F, Armstrong PW, Califf RM. International variation in invasive care of the elderly with acute coronary syndromes. Eur Heart J. 2006 Jul; 27(13):1558-64. PMID: 16760200.
    View in: PubMed
  98. Shishehbor MH, Topol EJ, Mukherjee D, Hu T, Cohen DJ, Stone GW, McClure R, Roffi M, Moliterno DJ. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol. 2006 Jun 1; 97(11):1585-90. PMID: 16728219.
    View in: PubMed
  99. Martin JL, Jia G, Martin SS, Shapiro TA, Herrmann HC, Dibattiste PM, Topol EJ, Moliterno DJ. The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice. Catheter Cardiovasc Interv. 2006 Apr; 67(4):563-70. PMID: 16532491.
    View in: PubMed
  100. Mukherjee D, Moliterno DJ. Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement. JAMA. 2006 Mar 15; 295(11):1307-9. PMID: 16531620.
    View in: PubMed
  101. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Harrington RA. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol. 2006 Feb 21; 47(4):809-16. PMID: 16487850.
    View in: PubMed
  102. Moliterno DJ, Steinhubl SR. Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both? JAMA. 2005 Sep 14; 294(10):1271-3. PMID: 16143697.
    View in: PubMed
  103. Chen MS, Bhatt DL, Chew DP, Moliterno DJ, Ellis SG, Topol EJ. Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med. 2005 Sep; 118(9):1019-25. PMID: 16164889.
    View in: PubMed
  104. Justice LT, Dauterman K, Smedira NG, Moliterno DJ. Left main dissection and thrombosis in a young athlete. Cardiol Rev. 2005 Sep-Oct; 13(5):260-2. PMID: 16106188.
    View in: PubMed
  105. Mukherjee D, Topol EJ, Bertrand ME, Kristensen SD, Herrmann HC, Neumann FJ, Yakubov SJ, Bassand JP, McClure RR, Stone GW, Ardissino D, Moliterno DJ. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up. Eur Heart J. 2005 Dec; 26(23):2524-8. PMID: 16107485.
    View in: PubMed
  106. Moliterno DJ. Healing Achilles--sirolimus versus paclitaxel. N Engl J Med. 2005 Aug 18; 353(7):724-7. PMID: 16105991.
    View in: PubMed
  107. Reddan DN, Szczech L, Bhapkar MV, Moliterno DJ, Califf RM, Ohman EM, Berger PB, Hochman JS, Van de Werf F, Harrington RA, Newby LK. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant. 2005 Oct; 20(10):2105-12. PMID: 16030030.
    View in: PubMed
  108. Steinhubl SR, Charnigo R, Moliterno DJ. Resistance to antiplatelet resistance is it justified? J Am Coll Cardiol. 2005 Jun 7; 45(11):1757-8. PMID: 15936601.
    View in: PubMed
  109. Mehta RH, Califf RM, Garg J, Pieper KS, Alexander JH, Moliterno DJ, Van de Werf F, Ohman EM, White HD, Topol EJ, Granger CB. Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy. Am J Cardiol. 2005 Jun 1; 95(11):1371-5. PMID: 15904648.
    View in: PubMed
  110. Gurjeva OS, Roe MT, Murphy SA, Moliterno DJ, Cannon CP. Unfortunate impact of age on the management and outcomes of unstable angina and non-ST elevation myocardial infarction (The GUARANTEE Registry). Crit Pathw Cardiol. 2005 Jun; 4(2):81-7. PMID: 18340189.
    View in: PubMed
  111. Berger PB, Best PJ, Topol EJ, White J, DiBattiste PM, Chan AW, Kristensen SD, Herrmann HC, Moliterno DJ. The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial. Am Heart J. 2005 May; 149(5):869-75. PMID: 15894970.
    View in: PubMed
  112. Mukherjee D, Topol EJ, Moliterno DJ, Brennan DM, Ziada K, Cho L, Steinhubl SR. Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment. Heart. 2006 Jan; 92(1):49-51. PMID: 15845611.
    View in: PubMed
  113. Das P, Moliterno DJ. Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS). J Thromb Thrombolysis. 2005 Apr; 19(2):105-13. PMID: 16052301.
    View in: PubMed
  114. Gomberg-Maitland M, Murphy SA, Moliterno DJ, Cannon CP. Are we appropriately triaging patients with unstable angina? Am Heart J. 2005 Apr; 149(4):613-8. PMID: 15990742.
    View in: PubMed
  115. Ferraris VA, Ferraris SP, Moliterno DJ, Camp P, Walenga JM, Messmore HL, Jeske WP, Edwards FH, Royston D, Shahian DM, Peterson E, Bridges CR, Despotis G. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg. 2005 Apr; 79(4):1454-61. PMID: 15797109.
    View in: PubMed
  116. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv. 2005 Mar; 64(3):369-72. PMID: 15736260.
    View in: PubMed
  117. Ohman EM, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb; 19(1):11-9. PMID: 15976962.
    View in: PubMed
  118. Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs. 2005; 5(6):399-408. PMID: 16259528.
    View in: PubMed
  119. Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials. Eur Heart J. 2005 Jan; 26(2):128-36. PMID: 15618068.
    View in: PubMed
  120. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004 Oct 6; 292(13):1555-62. PMID: 15467057.
    View in: PubMed
  121. Ellis SG, Bajzer CT, Bhatt DL, Brener SJ, Whitlow PL, Lincoff AM, Moliterno DJ, Raymond RE, Tuzcu EM, Franco I, Dushman-Ellis S, Lander KJ, Schneider JP, Topol EJ. Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv. 2004 Oct; 63(2):135-40. PMID: 15390245.
    View in: PubMed
  122. Asher CR, Moliterno DJ, Bhapkar MV, McGuire DK, Rao SV, Holmes DR, Newby LK, Bates ER, Topol EJ. Association of race with complications and prognosis following acute coronary syndromes. Am J Cardiol. 2004 Sep 15; 94(6):792-4. PMID: 15374792.
    View in: PubMed
  123. Saw J, Topol EJ, Steinhubl SR, Brennan D, Berger PB, Moliterno DJ. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. Am J Cardiol. 2004 Sep 1; 94(5):623-5. PMID: 15342293.
    View in: PubMed
  124. Kapadia SR, Moliterno DJ. Did we enjoy the debate but forget the patient? J Am Coll Cardiol. 2004 Aug 18; 44(4):775-7. PMID: 15312857.
    View in: PubMed
  125. Brener SJ, Moliterno DJ, Lincoff AM, Steinhubl SR, Wolski KE, Topol EJ. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation. 2004 Aug 24; 110(8):994-8. PMID: 15302778.
    View in: PubMed
  126. Vivekananthan DP, Bhatt DL, Chew DP, Zidar FJ, Chan AW, Moliterno DJ, Ellis SG, Topol EJ. Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. Am J Cardiol. 2004 Aug 1; 94(3):358-60. PMID: 15276105.
    View in: PubMed
  127. Das P, Moliterno DJ. Fractionating heparins and their clinical trial data--something for everyone. JAMA. 2004 Jul 7; 292(1):101-3. PMID: 15238598.
    View in: PubMed
  128. McCarthy JJ, Parker A, Salem R, Moliterno DJ, Wang Q, Plow EF, Rao S, Shen G, Rogers WJ, Newby LK, Cannata R, Glatt K, Topol EJ. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet. 2004 May; 41(5):334-41. PMID: 15121769.
    View in: PubMed
  129. Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation. 2004 May 11; 109(18):2203-6. PMID: 15117843.
    View in: PubMed
  130. Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, Harrington RA, Tardiff BE, Granger CB, Ohman EM, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, Califf RM, Topol EJ. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004 Feb; 25(4):313-21. PMID: 14984920.
    View in: PubMed
  131. McGuire DK, Newby LK, Bhapkar MV, Moliterno DJ, Hochman JS, Klein WW, Weaver WD, Pfisterer M, Corbalán R, Dellborg M, Granger CB, Van De Werf F, Topol EJ, Califf RM. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J. 2004 Feb; 147(2):246-52. PMID: 14760321.
    View in: PubMed
  132. Lee DS, Bhatt DL, Moliterno DJ, Peacock WF, Ellis SG, Topol EJ. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients. J Invasive Cardiol. 2004 Feb; 16(2):46-51. PMID: 14760188.
    View in: PubMed
  133. Wang Q, Rao S, Shen GQ, Li L, Moliterno DJ, Newby LK, Rogers WJ, Cannata R, Zirzow E, Elston RC, Topol EJ. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet. 2004 Feb; 74(2):262-71. PMID: 14732905.
    View in: PubMed
  134. Exaire JE, Dauerman HL, Topol EJ, Blankenship JC, Wolski K, Raymond RE, Cohen EA, Moliterno DJ. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J. 2004 Jan; 147(1):31-4. PMID: 14691415.
    View in: PubMed
  135. Casserly IP, Kereiakes DJ, Gray WA, Gibson PH, Lauer MA, Reginelli JP, Moliterno DJ. Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration. Thromb Res. 2004; 113(2):115-21. PMID: 15115666.
    View in: PubMed
  136. Brener SJ, Bhatt DL, Moliterno DJ, Schneider JP, Ellis SG, Topol EJ. Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation. Am J Cardiol. 2003 Dec 15; 92(12):1468-71. PMID: 14675590.
    View in: PubMed
  137. Mukherjee D, Hsu A, Moliterno DJ, Lincoff AM, Goormastic M, Topol EJ. Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old. Am J Cardiol. 2003 Dec 15; 92(12):1465-7. PMID: 14675589.
    View in: PubMed
  138. Newby LK, Bhapkar MV, White HD, Moliterno DJ, LaPointe NM, Kandzari DE, Verheugt FW, Kramer JM, Armstrong PW, Califf RM. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation. J Thromb Thrombolysis. 2003 Dec; 16(3):119-28. PMID: 15087598.
    View in: PubMed
  139. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, Topol EJ. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003 Oct 22; 290(16):2174-81. PMID: 14570953.
    View in: PubMed
  140. McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet. 2003 Dec; 114(1):87-98. PMID: 14557872.
    View in: PubMed
  141. Chan AW, Moliterno DJ, Berger PB, Stone GW, DiBattiste PM, Yakubov SL, Sapp SK, Wolski K, Bhatt DL, Topol EJ. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET). J Am Coll Cardiol. 2003 Oct 1; 42(7):1188-95. PMID: 14522478.
    View in: PubMed
  142. Ross MJ, Herrmann HC, Moliterno DJ, Blankenship JC, Demopoulos L, DiBattiste PM, Ellis SG, Ghazzal Z, Martin JL, White J, Topol EJ. Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial. J Am Coll Cardiol. 2003 Sep 17; 42(6):981-8. PMID: 13678916.
    View in: PubMed
  143. Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, Dippel EJ, Furman MI, Grines CL, Kleiman NS, Levine GN, Mann T, Nair RN, Stine RA, Yacubov SJ, Tcheng JE. A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9. PMID: 13678943.
    View in: PubMed
  144. Chiu JH, Topol EJ, Whitlow PL, Hsu AP, Tuzcu EM, Franco I, Moliterno DJ. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. Am J Cardiol. 2003 Sep 1; 92(5):582-3. PMID: 12943879.
    View in: PubMed
  145. Schoenhagen P, Tuzcu EM, Stillman AE, Moliterno DJ, Halliburton SS, Kuzmiak SA, Kasper JM, Magyar WA, Lieber ML, Nissen SE, White RD. Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: comparison of 16-slice computed tomography and intravascular ultrasound. Coron Artery Dis. 2003 Sep; 14(6):459-62. PMID: 12966267.
    View in: PubMed
  146. Yen MH, Bhatt DL, Chew DP, Harrington RA, Newby LK, Ardissino D, Van de Werf F, White JA, Moliterno DJ, Topol EJ. Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med. 2003 Sep; 115(4):318-21. PMID: 12967697.
    View in: PubMed
  147. Saw J, Moliterno DJ. Contemporary use of antiplatelet therapies in percutaneous coronary interventions. Coron Artery Dis. 2003 Aug; 14(5):373-80. PMID: 12878902.
    View in: PubMed
  148. Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FW, Berger PB, Moliterno DJ, White HD, Ohman EM, Van de Werf F, Topol EJ, Califf RM. Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol. 2003 Aug 1; 92(3):330-3. PMID: 12888148.
    View in: PubMed
  149. Casserly IP, Topol EJ, Jia G, Lange RA, Hamm C, Meier B, DiBattiste PM, Lakkis N, Chew DP, Stone GW, Cohen DJ, Moliterno DJ. Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial. Am J Cardiol. 2003 Jul 15; 92(2):125-9. PMID: 12860211.
    View in: PubMed
  150. McCarthy JJ, Lehner T, Reeves C, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ. Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet. 2003 Jun; 40(6):453-8. PMID: 12807968.
    View in: PubMed
  151. Cho L, Kottke-Marchant K, Lincoff AM, Roffi M, Reginelli JP, Kaldus T, Moliterno DJ. Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations. Am J Cardiol. 2003 May 1; 91(9):1110-3. PMID: 12714157.
    View in: PubMed
  152. Moliterno DJ, Penn MS. Angioplasty, inflammation, and antiplatelet agents. Am Heart J. 2003 Apr; 145(4):563-6. PMID: 12679746.
    View in: PubMed
  153. Cho L, Chew DP, Moliterno DJ, Roffi M, Ellis SG, Franco I, Bajzer C, Bhatt DL, Dorosti K, Simpfendorder C, Tuzcu M, Yadav JS, Brener S, Raymond R, Whitlow P, Topol EJ, Lincoff AM. Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition. Am J Cardiol. 2003 Mar 15; 91(6):742-3. PMID: 12633814.
    View in: PubMed
  154. Brener SJ, Midei MG, Nukta D, Kereiakes DJ, Rizik DG, Murphy D, Brennan D, Moliterno DJ. A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial. J Invasive Cardiol. 2003 Mar; 15(3):128-32. PMID: 12612386.
    View in: PubMed
  155. Moliterno DJ, Chan AW. Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET. J Am Coll Cardiol. 2003 Feb 19; 41(4 Suppl S):49S-54S. PMID: 12644341.
    View in: PubMed
  156. Quinn MJ, Moliterno DJ. Diabetes and percutaneous coronary intervention: the sweet smell of success? Am Heart J. 2003 Feb; 145(2):203-5. PMID: 12595833.
    View in: PubMed
  157. Saw J, Kereiakes DJ, Mahaffey KW, Applegate RJ, Braden GA, Brent BN, Brodie BR, Groce JB, Levine GN, Leya F, Moliterno DJ. Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thromb Res. 2003; 112(5-6):301-6. PMID: 15041274.
    View in: PubMed